APA (7th ed.) Citation

Zheng, N., Chen, Y., Luo, S., Luo, J., Bahediyaer, A., Su, S., . . . Wang, J. (2026). Flavokawain A Targets CXCR4 ‐Mediated Vasculogenic Mimicry to Reverse Hepatocellular Carcinoma Resistance to Tyrosine Kinase Inhibitors. Wiley. https://doi.org/10.1002/ptr.70360

Chicago Style (17th ed.) Citation

Zheng, Ning, Yan Chen, Shijie Luo, Jialin Luo, Ayixuwake Bahediyaer, Shizhen Su, Lixian Wu, and Jichuang Wang. Flavokawain A Targets CXCR4 ‐Mediated Vasculogenic Mimicry to Reverse Hepatocellular Carcinoma Resistance to Tyrosine Kinase Inhibitors. Wiley, 2026. https://doi.org/10.1002/ptr.70360.

MLA (9th ed.) Citation

Zheng, Ning, et al. Flavokawain A Targets CXCR4 ‐Mediated Vasculogenic Mimicry to Reverse Hepatocellular Carcinoma Resistance to Tyrosine Kinase Inhibitors. Wiley, 2026. https://doi.org/10.1002/ptr.70360.